CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86

Futu NewsNov 19 20:33 · Ratings

Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential

TipRanksNov 19 19:56 · Ratings

HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target

BenzingaNov 19 01:13 · Ratings

Sector Update: Health Care Stocks Mixed Premarket Monday

MT NewswiresNov 18 22:19

Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year

MT NewswiresNov 18 21:09

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder

BusinesswireNov 18 20:00